| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/22/2004 | WO2004006961A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 01/22/2004 | WO2004006960A1 Transdermal absorption preparation |
| 01/22/2004 | WO2004006959A1 Liquid dosage compositions of stable nanoparticulate active agents |
| 01/22/2004 | WO2004006958A1 Stable pharmaceutical composition comprising erythropoietin |
| 01/22/2004 | WO2004006957A1 Pharmaceutical compositions for otic use |
| 01/22/2004 | WO2004006954A2 Transdermal botulinum toxin compositions |
| 01/22/2004 | WO2004006953A2 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 01/22/2004 | WO2004006948A1 Stable pharmaceutical composition comprising erythropoietin |
| 01/22/2004 | WO2004006945A1 Tablet composition containing chinese orthodox medicine extract and process for producing the same |
| 01/22/2004 | WO2004006942A1 Method for sustaining direct cell delivery |
| 01/22/2004 | WO2004006937A2 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same |
| 01/22/2004 | WO2004006930A1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 01/22/2004 | WO2004006929A1 Composition for nasal absorption |
| 01/22/2004 | WO2004006921A1 Process for producing coated preparation |
| 01/22/2004 | WO2004006917A1 Dispersible tablets for oral administration |
| 01/22/2004 | WO2004006905A1 Modafinil pharmaceutical compositions |
| 01/22/2004 | WO2004006904A1 Oral controlled-release dosage forms containing acetaminophen |
| 01/22/2004 | WO2004006899A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 01/22/2004 | WO2004006897A1 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds |
| 01/22/2004 | WO2004006896A1 Oral care capsules |
| 01/22/2004 | WO2004006895A1 Lasofoxifene tablet and its coating |
| 01/22/2004 | WO2004006894A1 Medicaments containing vardenafil hydrochloride trihydrate |
| 01/22/2004 | WO2004006893A1 Method for particle precipitation using near-critical and supercritical antisolvents |
| 01/22/2004 | WO2004006892A1 Implantable orthopedic surgical devices with controlled release antimicrobial component |
| 01/22/2004 | WO2004006891A2 Delivery system for pharmaceutical agents |
| 01/22/2004 | WO2004006890A1 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 01/22/2004 | WO2004006889A1 Bioerodible film for ophthalmic drug delivery |
| 01/22/2004 | WO2004006888A2 Stabilization of the profile of release of active substances from a formulation |
| 01/22/2004 | WO2004006886A2 Injectable depot formulation comprising crystals of iloperidone |
| 01/22/2004 | WO2004006885A2 Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect |
| 01/22/2004 | WO2004006884A2 Process for providing a stable crystalline form of salbutamol |
| 01/22/2004 | WO2004006863A2 Therapeutic devices for patterned cell growth |
| 01/22/2004 | WO2004006765A1 Delivery of therapeutic agent affixed to magnetic particle |
| 01/22/2004 | WO2004006692A1 Improved bulking agent compositions |
| 01/22/2004 | WO2004006668A1 Treatment of teats or udders of mammals after milking with barrier-forming foam systems |
| 01/22/2004 | WO2003092649A3 Reduced formate poly(alkylene oxides) with secondary amines for reducing impurity formation |
| 01/22/2004 | WO2003092590A3 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 01/22/2004 | WO2003086290A3 Electroprocessing of materials useful in drug delivery and cell encapsulation |
| 01/22/2004 | WO2003082213A3 Compositions and methods for delivering pharmaceutically active agents using nanoparticulates |
| 01/22/2004 | WO2003080028A3 Method and apparatus for producing dry particles |
| 01/22/2004 | WO2003076391A3 Urokinase inhibitors, production and use thereof |
| 01/22/2004 | WO2003072022A3 Oral trimethobenzamide formulations and methods |
| 01/22/2004 | WO2003068161A3 Composition and method for protecting labile active components |
| 01/22/2004 | WO2003068049A3 Controlled cerebrospinal infusion and shunt system |
| 01/22/2004 | WO2003066022A3 Stable pharmaceutical composition useful for treating gastrointestinal disorders |
| 01/22/2004 | WO2003061402A3 Reduction of renal damage in companion animals |
| 01/22/2004 | WO2003051979A3 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 01/22/2004 | WO2003045326A3 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 01/22/2004 | WO2003041637A3 Lyophilized monoclonal antibody compositions |
| 01/22/2004 | WO2003037244A3 System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing |
| 01/22/2004 | WO2003024421A3 Triclosan dosage form |
| 01/22/2004 | WO2002092573A3 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 01/22/2004 | US20040016013 Achieves widespread distribution, systemic expression and sustained delivery in the animal; oral gene therapy |
| 01/22/2004 | US20040015214 Photodynamic therapy for the treatment of hair loss |
| 01/22/2004 | US20040015154 Implantable devices with invasive and non-invasive reversible infusion rate adjustability |
| 01/22/2004 | US20040014961 Soluble highly branched glucose polymers and their method of production |
| 01/22/2004 | US20040014819 Otic compositions are disclosed. The compositions contain an otic drug and a carrier comprising a low molecular weight compound. The compositions do not drain out of the ear after administration. |
| 01/22/2004 | US20040014817 Stable dosage forms containing ubiquinones |
| 01/22/2004 | US20040014812 Promote production and secretion of mucin in ophthalmic tissues. Therapeutic agents for keratoconjunctival diseases in the present invention comprise farnesylacetic acid or a salt thereof as an active ingredient. |
| 01/22/2004 | US20040014794 Use of hydroxypyridone-derivatives in wound healing |
| 01/22/2004 | US20040014761 Treatment of female sexual dysfunction with phosphodiesterase inhibitors |
| 01/22/2004 | US20040014750 Therapy, prevention atherosclerosis; cardiovascular disorders; anticholesterol agents; bactericides; prevention infections |
| 01/22/2004 | US20040014749 Sulfhydryl rifamycins and uses thereof |
| 01/22/2004 | US20040014718 Clear aqueous anaesthetic composition |
| 01/22/2004 | US20040014716 Composition for soluble films with a new hydrolyzed polysaccharide |
| 01/22/2004 | US20040014714 Method for producing a crystalline tableting additive, additive thus obtained and use thereof |
| 01/22/2004 | US20040014709 Genetic engineered adenoviral vector coding interferon gene; therapy against bladder cancer |
| 01/22/2004 | US20040014708 Composition comprising immunogenic microparticles |
| 01/22/2004 | US20040014704 Reducing immunology response; sustained release |
| 01/22/2004 | US20040014700 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents |
| 01/22/2004 | US20040014698 Oral administration of therapeutic agent coupled to transporting agent |
| 01/22/2004 | US20040014680 Mixing drug with sugar alcohol and, or (mono- or di-)saccharide; low melting point; compression; heating |
| 01/22/2004 | US20040014679 Headache therapy |
| 01/22/2004 | US20040014655 Pharmaceutical compositions containing plasma protein |
| 01/22/2004 | US20040014590 Modulation pressure; efficient solvent extraction |
| 01/22/2004 | US20040014212 Culturing pancreatic tissues for treatment of diabetes; animal models; tissue engineering |
| 01/22/2004 | US20040014188 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| 01/22/2004 | US20040014164 Dried composition comprised of glassy matrix for improving stability and storage of proteins |
| 01/22/2004 | US20040014100 Methods and compositions utilizing inteins to generate libraries of cyclic peptides in vivo |
| 01/22/2004 | US20040014084 Method for drying water-borne materials |
| 01/22/2004 | US20040013767 A free-flowing powder is compressed to form tablets |
| 01/22/2004 | US20040013752 Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances |
| 01/22/2004 | US20040013747 An anaesthetic mixture comprising a drug, acids, a metal nitrite; a membrane is used to prevent direct contact of the skin while diffusing the active drug and nitric oxide vasodilator; topical application |
| 01/22/2004 | US20040013746 Antidepressants for treating manic disorders, psychosis, comprising ethyl cellulose, talc, polyvinylpyrrolidone |
| 01/22/2004 | US20040013744 Antibiotic ointment for treating skin rash; simple and inexpensive |
| 01/22/2004 | US20040013738 Encapsulation of liquid template particles |
| 01/22/2004 | US20040013737 Mixture with ethyl cellulose and acrylic polymer |
| 01/22/2004 | US20040013736 Twin screw extrusion; cellulose ether carrier; mixture containing sugar alcohols |
| 01/22/2004 | US20040013735 Drying, mixing with binder; controlling particle sizes |
| 01/22/2004 | US20040013734 Mixture of water insoluble drug and polymer |
| 01/22/2004 | US20040013733 Preparation of a biodegradable thermal-sensitive gel system |
| 01/22/2004 | US20040013732 Starch-based delivery system for creatine |
| 01/22/2004 | US20040013731 Drug-complex microparticles and methods of making/using same |
| 01/22/2004 | US20040013730 Insertion into vagina; prevention, therapy for infections |
| 01/22/2004 | US20040013729 Mydriatic agent in viscoelasticity polymer |
| 01/22/2004 | US20040013728 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 01/22/2004 | US20040013727 Hydrophilic gel foaming matrix; cellulose ethers |
| 01/22/2004 | US20040013726 Granulation, crosslinking, drying to powder |
| 01/22/2004 | US20040013725 Storage stable thyroxine active drug formulations and methods for their production |
| 01/22/2004 | US20040013724 Use of dicalcium phosphate anhydride powder |